miRNAs as potential therapeutic targets for age-related macular degeneration

Shusheng Wang, Kyle M. Koster, Yuguang He, Qinbo Zhou

Research output: Contribution to journalArticle

36 Scopus citations


Since their recent discovery, miRNAs have been shown to play critical roles in a variety of pathophysiological processes. Such processes include pathological angiogenesis, the oxidative stress response, immune response and inflammation, all of which have been shown to have important and interdependent roles in the pathogenesis and progression of age-related macular degeneration (AMD). Here we present a brief review of the pathological processes involved in AMD and review miRNAs and other noncoding RNAs involved in regulating these processes. Specifically, we discuss several candidate miRNAs that show promise as AMD therapeutic targets due to their direct involvement in choroidal neovascularization or retinal pigment epithelium atrophy. We discuss potential miRNA-based therapeutics and delivery methods for AMD and provide future directions for the field of miRNA research with respect to AMD. We believe the future of miRNAs in AMD therapy is promising.

Original languageEnglish (US)
Pages (from-to)277-287
Number of pages11
JournalFuture Medicinal Chemistry
Issue number3
Publication statusPublished - Mar 2012


ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this